CAST-HF Trial

Cardiac Shockwave Therapy for ischemic Cardiomyopathy adjunctive to CABG surgery - we make Heart Regeneration Reality!

[CAST-HF Trial @CastTrial]

Today Michael Graber from the CARE Lab (https://t.co/40wA28mIrj) completed his PhD Defensio with distinction! We are proud of him and his major contribution to shockwave therapy with regard to the transdifferentiation of cardiac fibroblasts to functional endothelial cells!

[CAST-HF Trial @CastTrial]

Check out this Article from JoVE in which we describe how to apply shockwaves in a murine model:
https://t.co/0akZzb4TB2

[CAST-HF Trial @CastTrial]

Shock Wave Therapy for the Ischemic Heart (J. Cooke, MD, L. Lai, PhD, J.... https://t.co/fhIzU9bbE9 via @YouTube
Our PI was featured at Houston Methodist Hospitals DeBakey Cardiovascular Science Series talking about Cardiac Shockwave Therapy. Great show!

[CAST-HF Trial @CastTrial]

Happy to share our newest publication on the therapeutic range of cardiac shockwave therapy. A puzzle piece that was missing as an important argument especially with regard to our cardiac application.

https://t.co/g0vM06Wxjw

#HeartFailure #shockwave #regenerativemedicine

[CAST-HF Trial @CastTrial]

The JCI Insight paper on traumatic spinal cord injury is a follow up to our earlier work on ischemic spinal cord injury:

https://t.co/rOHL7A1EtR

[CAST-HF Trial @CastTrial]

Proud to present our landmark paper on shockwave therapy for traumatic spinal cord injury!

https://t.co/WJMBVpeUDh

#shockwave #regeneration #spine

[CAST-HF Trial @CastTrial]

Happy to share our newest manuscript: The study protocol of the CAST-HF Trial was published in Trials.

https://t.co/8FFpsOdF2C

https://t.co/MbOilX6z0x

#HeartFailure #shockwave #regeneration #heartsurgery

[Christoph Binder @cj_binder]

Our consortium on "B-cells in Cardiovascular Disease"was selected by @FondationLeducq for their Transatlantic Networks of Excellence Program.
Excited to work with @SwirskiLab @ZMallat SMalin CMcNamara SPillai on novel #immunotherapy approaches for #CVD
👇
https://t.co/q3QGP3FEz4

[CAST-HF Trial @CastTrial]

Heart failure is ever increasing and a central topic at this years Cardiology Congress in Innsbruck. CAST-HF trial PI Johannes Holfeld gives a keynote lecture on surgical heart failure treatment.
#HeartFailure #Cardiology #HeartSurgeons

[CAST-HF Trial @CastTrial]

Medical University of Innsbruck featured our current research findings on cardiac shockwave therapy only recently on its website:

#shockwave #regeneration

[CAST-HF Trial @CastTrial]

Right in time to New Year's Eve 'Science Advances' published an article on shockwaves occurring during champagne cork popping! Cheers! 🥂

https://t.co/Utj3p64hl8

#shockwave #champagne

[CAST-HF Trial @CastTrial]

RT HeartRegen: keep it up! https://t.co/fvdaXfzHR0 https://t.co/OYXAaXoyHp

[CAST-HF Trial @CastTrial]

https://t.co/40wA28mIrj, the research group behind @CastTrial is trying to get a new picture of its group members. See one preliminary example here from the rooftop shooting on the heliport of @imed_tweets.

[CAST-HF Trial @CastTrial]

https://t.co/40wA28mIrj, the research group behind @CastTrial is trying to get a new picture of its group members. See one preliminary example here from the rooftop shooting on the heliport of @imed_tweets.

[Giuseppe Galati @GiuseppeGalati_]

Correct # is #HFA_ESC. Just for info @ShelleyZieroth @MihaiTrofenciuc @SABOURETCardio @AnastasiaSMihai @hvanspall @DrLadyMaria1 @EkateriniL @paomorejon @JGrapsa @MarcoMetra @zhh_ch @CanHFSociety @CCF_cardio

[CAST-HF Trial @CastTrial]

#RT @HeaRTRegen: RT @CastTrial: Congratulations to Can Gollmann-Tepeköylü from the Cardiosurgical Research Lab at @imed_tweets (https://t.co/40wA28mIrj) for winning a highly recognized Alumni Scientia Award! The laudatio was given by Gerd Silberhumer fro…

[CAST-HF Trial @CastTrial]

Congratulations to Can Gollmann-Tepeköylü from the Cardiosurgical Research Lab at @imed_tweets (https://t.co/40wA28mIrj) for winning a highly recognized Alumni Scientia Award! The laudatio was given by Gerd Silberhumer from @MedUni_Wien. Can serves as a Co-I at the @CastTrial

[CAST-HF Trial @CastTrial]

On Friday Gregor Holfeld, CFO of our industry partner @HeaRTRegen, presented the business case of cardiac shockwave therapy at the Tyrolean Chamber of Economics @WKOe. The @CastTrial has a huge socio-economic impact! #shockwave #heartregeneration #MedTech #medicine

[JAMA @JAMA_current]

~570 US businesses offer #stemcell therapy, at least 61 of which market it to patients with #heartfailure. Since the treatment is not supported by evidence or approved by @US_FDA, regulatory action needs to be directed to these unauthorized activities. https://t.co/45nScUnAW1

[CAST-HF Trial @CastTrial]

@JAMA_current The result is not so surprising. What is hard to unterstand is the title of this publication which does in no way reflect the conclusion of the work.
Btw, alternatives to (stem) cell therapies for ischemic cardiomyopathy are underway, have a look to @CastTrial

[CAST-HF Trial @CastTrial]

These findings do not support the use of mesenchymal precursors in heart failure patients!
#heartfailure #heartregeneration #cardiovascular #shockwave

[JAMA @JAMA_current]

In this phase 2 randomized trial, injection of mesenchymal precursor cells into the myocardium of patients with heart failure did not repair myocardial damage enough to facilitate weaning from LVADs at 6 months compared to sham injections. https://t.co/A5IFCfd7uz